Primary Biliary Cholangitis Pbc clinical trials

Explore recruiting primary biliary cholangitis pbc clinical trials.

Recruiting primary biliary cholangitis pbc studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Primary Biliary Cholangitis Pbc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Double-Blind, Randomized, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Obeticholic Acid Administered in Combination with Bezafibrate in Subjects with Primary Biliary Cholangitis Who Had an Inadequate Response or Who Were Unable to Tolerate Ursodeoxycholic Acid

Germany, Norway, Hungary, Spain, Belgium, Croatia +6 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Open-Label, Long-Term Safety Extension Study Evaluating the Safety and Tolerability of the Fixed-Dose Combination of Obeticholic Acid and Bezafibrate in Subjects with Primary Biliary Cholangitis

Netherlands, France, Norway, Hungary, Italy, Lithuania +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomised, double-blind, placebo-controlled, two-part study to evaluate the pharmacokinetics, safety and tolerability, and preliminary efficacy of two dose levels of golexanolone in subjects with primary biliary cholangitis, fatigue, and cognitive dysfunction.

Hungary, Spain, Italy, Germany, Greece

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2b/3 Study to Evaluate the Efficacy and Safety of Saroglitazar Magnesium in Subjects with Primary Biliary Cholangitis

Iceland

Phase II and Phase III (Integrated) EU CTIS Study details

ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Czechia, Belgium, Spain, Hungary, Italy, Netherlands +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2a, Double-Blind, Randomized, Active Controlled, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Bezafibrate Administered in Combination with Obeticholic Acid in Subjects with Primary Biliary Cholangitis

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Primary Biliary Cholangitis Pbc trials by city

Primary Biliary Cholangitis Pbc in Toronto Primary Biliary Cholangitis Pbc in Vancouver Primary Biliary Cholangitis Pbc in Montreal Primary Biliary Cholangitis Pbc in Calgary Primary Biliary Cholangitis Pbc in Edmonton Primary Biliary Cholangitis Pbc in Ottawa Primary Biliary Cholangitis Pbc in Winnipeg Primary Biliary Cholangitis Pbc in Quebec City Primary Biliary Cholangitis Pbc in Hamilton Primary Biliary Cholangitis Pbc in Kitchener Primary Biliary Cholangitis Pbc in London Primary Biliary Cholangitis Pbc in Halifax Primary Biliary Cholangitis Pbc in New York Primary Biliary Cholangitis Pbc in Los Angeles Primary Biliary Cholangitis Pbc in Chicago Primary Biliary Cholangitis Pbc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease